VABu Conditioning in Elderly AML HSCT

Abroad (travel likely)RecruitingPHASE2, PHASE3

Conditions

Allogeneic Hematopoietic Stem Cell Transplantation Recipient · Acute Myeloid Leukemia (AML)

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu, China
Contact: Study coordinator (Xin Kong) · mumukongxin@hotmail.com · 67781856

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Naive T Cell Depletion for Preventing Chronic Graft-versus-Host Disease in Children and Young Adults With Blood Cancers Undergoing Donor Stem Cell Transplant

Acute Biphenotypic Leukemia · Acute Leukemia · Acute Leukemia of Ambiguous Lineage

Abroad (travel likely)RecruitingPHASE2

Los Angeles, United States · Washington D.C., United States

Prehabilitation for Patients Diagnosed With Blood Cancer and Treated With Al-logeneic Hematopoietic Stem Cell Transplantation

Allogeneic Hematopoietic Stem Cell Transplantation Recipient

Abroad (travel likely)Recruiting

Copenhagen, Denmark

Donor Virus-Specific CMV or AdV CTL to Treat CMV or AdV Reactivation or Disease After Solid Organ or HCT

Allogeneic Hematopoietic Stem Cell Transplantation Recipient · Cytomegalovirus · Donor

Abroad (travel likely)RecruitingEARLY_PHASE1

Columbus, United States · Columbus, United States